Literature DB >> 25162514

Pediatric severe sepsis in U.S. children's hospitals.

Fran Balamuth1, Scott L Weiss, Mark I Neuman, Halden Scott, Patrick W Brady, Raina Paul, Reid W D Farris, Richard McClead, Katie Hayes, David Gaieski, Matt Hall, Samir S Shah, Elizabeth R Alpern.   

Abstract

OBJECTIVES: To compare the prevalence, resource utilization, and mortality for pediatric severe sepsis identified using two established identification strategies.
DESIGN: Observational cohort study from 2004 to 2012.
SETTING: Forty-four pediatric hospitals contributing data to the Pediatric Health Information Systems database. PATIENTS: Children 18 years old or younger.
MEASUREMENTS AND MAIN RESULTS: We identified patients with severe sepsis or septic shock by using two International Classification of Diseases, 9th edition, Clinical Modification-based coding strategies: 1) combinations of International Classification of Diseases, 9th edition, Clinical Modification codes for infection plus organ dysfunction (combination code cohort); 2) International Classification of Diseases, 9th edition, Clinical Modification codes for severe sepsis and septic shock (sepsis code cohort). Outcomes included prevalence of severe sepsis, as well as hospital and ICU length of stay, and mortality. Outcomes were compared between the two cohorts examining aggregate differences over the study period and trends over time. The combination code cohort identified 176,124 hospitalizations (3.1% of all hospitalizations), whereas the sepsis code cohort identified 25,236 hospitalizations (0.45%), a seven-fold difference. Between 2004 and 2012, the prevalence of sepsis increased from 3.7% to 4.4% using the combination code cohort and from 0.4% to 0.7% using the sepsis code cohort (p < 0.001 for trend in each cohort). Length of stay (hospital and ICU) and costs decreased in both cohorts over the study period (p < 0.001). Overall, hospital mortality was higher in the sepsis code cohort than the combination code cohort (21.2% [95% CI, 20.7-21.8] vs 8.2% [95% CI, 8.0-8.3]). Over the 9-year study period, there was an absolute reduction in mortality of 10.9% (p < 0.001) in the sepsis code cohort and 3.8% (p < 0.001) in the combination code cohort.
CONCLUSIONS: Prevalence of pediatric severe sepsis increased in the studied U.S. children's hospitals over the past 9 years, whereas resource utilization and mortality decreased. Epidemiologic estimates of pediatric severe sepsis varied up to seven-fold depending on the strategy used for case ascertainment.

Entities:  

Mesh:

Year:  2014        PMID: 25162514      PMCID: PMC4221502          DOI: 10.1097/PCC.0000000000000225

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  26 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Historical perspective of the word "sepsis".

Authors:  Stefanos Geroulanos; Evangelia T Douka
Journal:  Intensive Care Med       Date:  2006-10-13       Impact factor: 17.440

3.  The epidemiology of severe sepsis in children in the United States.

Authors:  R Scott Watson; Joseph A Carcillo; Walter T Linde-Zwirble; Gilles Clermont; Jeffrey Lidicker; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

Review 5.  International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.

Authors:  Brahm Goldstein; Brett Giroir; Adrienne Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-01       Impact factor: 3.624

6.  Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.

Authors:  Simon Nadel; Brahm Goldstein; Mark D Williams; Heidi Dalton; Mark Peters; William L Macias; Shamel A Abd-Allah; Howard Levy; Robinette Angle; Dazhe Wang; David P Sundin; Brett Giroir
Journal:  Lancet       Date:  2007-03-10       Impact factor: 79.321

7.  Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services.

Authors:  C Feudtner; R M Hays; G Haynes; J R Geyer; J M Neff; T D Koepsell
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

8.  Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis.

Authors:  Folafoluwa O Odetola; Achamyeleh Gebremariam; Gary L Freed
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

9.  Mortality rates in pediatric septic shock with and without multiple organ system failure.

Authors:  Martha C Kutko; Michael P Calarco; Maryellen B Flaherty; Robert F Helmrich; H Michael Ushay; Steven Pon; Bruce M Greenwald
Journal:  Pediatr Crit Care Med       Date:  2003-07       Impact factor: 3.624

Review 10.  Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock.

Authors:  Joseph A Carcillo; Alan I Fields
Journal:  Crit Care Med       Date:  2002-06       Impact factor: 7.598

View more
  96 in total

1.  Comparison of Methods for Identification of Pediatric Severe Sepsis and Septic Shock in the Virtual Pediatric Systems Database.

Authors:  Robert B Lindell; Akira Nishisaki; Scott L Weiss; Fran Balamuth; Danielle M Traynor; Marianne R Chilutti; Robert W Grundmeier; Julie C Fitzgerald
Journal:  Crit Care Med       Date:  2019-02       Impact factor: 7.598

2.  Pediatric Outcomes After Regulatory Mandates for Sepsis Care.

Authors:  Kristin H Gigli; Billie S Davis; Jonathan G Yabes; Chung-Chou H Chang; Derek C Angus; Tina Batra Hershey; Jennifer R Marin; Grant R Martsolf; Jeremy M Kahn
Journal:  Pediatrics       Date:  2020-07       Impact factor: 7.124

Review 3.  Gene Expression Profiles in Children With Suspected Sepsis.

Authors:  Fran Balamuth; Elizabeth R Alpern; Mengyuan Kan; Maya Shumyatcher; Katie Hayes; Ebbing Lautenbach; Blanca E Himes
Journal:  Ann Emerg Med       Date:  2020-01-23       Impact factor: 5.721

4.  A Biosignature Predicting Complicated Course in Children Presenting with Septic Shock. Why PERSEVERE?

Authors:  Adrienne G Randolph
Journal:  Am J Respir Crit Care Med       Date:  2017-08-15       Impact factor: 21.405

5.  Automating a Manual Sepsis Screening Tool in a Pediatric Emergency Department.

Authors:  Julia K Lloyd; Erin A Ahrens; Donnie Clark; Terri Dachenhaus; Kathryn E Nuss
Journal:  Appl Clin Inform       Date:  2018-10-31       Impact factor: 2.342

6.  Creating Consensus Educational Goals for Pediatric Sepsis via Multicenter Modified Delphi.

Authors:  Jason M Woods; Halden F Scott; Pavan P Zaveri
Journal:  AEM Educ Train       Date:  2018-09-17

7.  Combatting Sepsis: A Public Health Perspective.

Authors:  Raymund B Dantes; Lauren Epstein
Journal:  Clin Infect Dis       Date:  2018-09-28       Impact factor: 9.079

8.  Readmission Diagnoses After Pediatric Severe Sepsis Hospitalization.

Authors:  Erin F Carlton; Joseph G Kohne; Manu Shankar-Hari; Hallie C Prescott
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

Review 9.  Part 12: Pediatric Advanced Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Allan R de Caen; Marc D Berg; Leon Chameides; Cheryl K Gooden; Robert W Hickey; Halden F Scott; Robert M Sutton; Janice A Tijssen; Alexis Topjian; Élise W van der Jagt; Stephen M Schexnayder; Ricardo A Samson
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

Review 10.  Sepsis in Pediatric Cardiac Intensive Care.

Authors:  Derek S Wheeler; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.